ROWNAK HASAN: Open Payments
NPI 1497761019 · WESTLAND, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,009 in 40 payments from 10 companies in 2025. Trend: 2023 $971 · 2024 $999 · 2025 $1,009
Food & beverage: $1,009
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 11 | $306 |
| ABBVIE INC. | 11 | $239 |
| Axsome Therapeutics, Inc. | 4 | $167 |
| Janssen Pharmaceuticals, Inc | 3 | $74 |
| Neurocrine BioSciences, Inc. | 2 | $51 |
| E.R. Squibb & Sons, L.L.C. | 2 | $50 |
| Vanda Pharmaceuticals Inc. | 3 | $49 |
| Teva Pharmaceuticals USA, Inc. | 2 | $30 |
| Alkermes, Inc. | 1 | $27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
Products named: VRAYLAR, REXULTI, Auvelity, ABILIFY ASIMTUFII, INVEGA SUSTENNA, INGREZZA, COBENFY, FANAPT.
Industry payments across MI — which companies pay providers there.
